
Reset all filters
01 2Tepezza
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 448
2022 Revenue in Millions : 0
Growth (%) : Acquired from Horizon
Main Therapeutic Indication : Immunology
Currency : USD
2024 Revenue in Millions : 1,851
2023 Revenue in Millions : 448
Growth (%) : 313